Micron has extensive experience in devising clinical development across all phases, from detailed evaluation of the target indication, including evaluation of an unmet need, to formulation of a comprehensive strategy for a drug’s clinical research programme.
Our dedicated and professional clinical research team have extensive experience in regulatory activities. Whether it is an initial submission to a regulatory body or a consultation on regulatory affairs, we excel at providing tailored high-quality services to our clients.
The Micron Group can arrange for contributions from qualified medical experts to support efficient, user-friendly adjudication workflows, and give expert opinions about clinical safety or efficacy events of interest. Our global network of clinical key opinion leaders and regulatory experts can either convene independently, or in conjunction with our clinical trial sponsors, to serve as committee members or individual advisors to clients.